Defining and Predicting Response to Hypomethylating Agents in Myelodysplastic Syndrome

2 Views

07/04/23

In this segment, panelists discuss the lack of a clear connection between response to hypomethylating agents and molecular genetics as well as the larger role for cytogenetic assessment of response for patients with myelodysplastic syndrome.

For more from this discussion, visit http://www.onclive.com/peer-exchange/mds-cml